USPSTF Again Backs Universal Screening for Gestational Diabetes
Clinicians should continue to screen for gestational diabetes in all asymptomatic pregnant patients during the second trimester, according to a recommendation from the U.S. Preventive Services Task Force (USPSTF). Providers should screen for gestational diabetes at 24 weeks’ gestation or later to improve maternal and fetal outcomes (grade B recommendation), stated Karina W. Davidson, PhD, […]
New study reveals serious long-term complications in youth-onset type 2 diabetes
Phil Zeitler, MD, PhD, has been treating youth with type 2 diabetes for more than 20 years. He and a team of researchers published a paper today on the TODAY2 study in the New England Journal of Medicine on the long-term complications of type 2 diabetes. (TODAY stands for Treatment Options for type 2 Diabetes […]
No more finger pricks: A continuous glucose monitor benefits patients with diabetes in more ways than one
A 15-center study of 175 patients with poorly controlled type 2 diabetes in JAMA found that continuous glucose monitoring, compared to blood glucose meter monitoring, or finger pricking, significantly decreased their hemoglobin A1C over eight months (-1.1% versus -0.16%, respectively.) Although the benefits of continuous glucose monitoring for patients with diabetes has been demonstrated before, […]
AHA News: Diabetes and Dementia Risk: Another Good Reason to Keep Blood Sugar in Check
Latest Diabetes News WEDNESDAY, July 21, 2021 (American Heart Association News) There are many reasons to avoid getting diabetes, or to keep it controlled if you already have it: Higher risks for heart disease, stroke and for having a foot or leg amputation. But here’s another one: It’s a major risk factor for […]
Hospitalization Rates for New-Onset Type 2 Diabetes in Kids Took Off During Pandemic
Young people were more likely to be initially diagnosed with type 2 diabetes (T2D) during the pandemic, while there was a significant increase in the number of new-onset pediatric T2D cases during the first 9 months of the COVID-19 crisis, researchers reported. Most of these cases involved non-Hispanic Black children and males, according to presentations […]
‘Modest’ Erectile Dysfunction Benefit With GLP-1 Agonist
GLP-1 receptor agonist treatment in men with type 2 diabetes may thwart some new cases of erectile dysfunction, an exploratory analysis of a randomized trial suggested. The findings, from the Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) trial, showed that slightly fewer men developed erectile dysfunction while on long-term treatment with once-weekly […]